This new series profiles the members of edie's 30 Under 30 - a nomination-based community of 30 hugely talented young ...

Genpact's President and CEO, Balkrishan "BK" Kalra, expressed confidence in the company's trajectory, highlighting strong quarterly growth, particularly in the Data-Tech-AI segment, and a record $5.7 ...

The widely followed cryptocurrency analyst Benjamin Cowen is warning that Ethereum (ETH) could slide further against Bitcoin ...

TD Cowen analyst Phil Nadeau maintained a Buy rating on Kura Oncology (KURA – Research Report) today. The company’s shares closed yesterday at ...

TD Cowen reinstated coverage on Tempus AI with a "Buy" rating and raised its price target to $74 after the health-tech ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

President Donald Trump has continued his shake-up of NLRB leadership by firing Acting General Counsel (GC) Jessica Rutter and replacing her ...

TD Cowen adjusted its outlook on Alphabet stock (NASDAQ:GOOGL), decreasing the price target to $220 from the previous $225. The firm, however, continues to recommend a Buy rating for the tech giant's ...

Noting that Ambry is a profitable testing laboratory that generates more than $300 million of revenue annually, the investment bank thinks that the deal will enable TEM to start generating positive ...

In a report released today, Marc Bianchi from TD Cowen maintained a Buy rating on NOV (NOV – Research Report), with a price target of $22.00.

After a winter storm dumped more rain into the Basin after a relatively dry winter, Barton Hospital’s new site on Highway 50 ...